Episode Details
Back to Episodes
Liquid Biopsy Could Predict Cancer Return | Canada News
Description
A groundbreaking blood test may soon help predict if cancer will return after treatment—by detecting microscopic tumor DNA invisible to scans. In the massive SHERLOCK trial, 7,000 cancer survivors are being monitored for up to five years to see if this liquid biopsy can reliably forecast recurrence and guide next steps. While early studies show a strong link between positive tests and cancer comeback, the test isn’t yet standard—and more research is needed. For patients haunted by the fear of relapse, this could be a game-changer, offering clarity and potentially life-saving interventions before cancer strikes again.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/298ae02b27b61409